In women with vulvodynia, topical gabapentin brings significant pain relief.
In women with vulvodynia, topical gabapentin brings significant pain relief, according to study findings published in the September issue of Obstetrics and Gynecology.
Lori A. Boardman, MD, of the Women and Infants' Hospital of Rhode Island in Coventry, RI, and colleagues conducted a retrospective study of 51 patients-including 19 with generalized vulvodynia and 32 with localized vulvodynia-who were treated with 2% to 6% gabapentin between 2001 and 2006.
Of the 35 evaluable women who completed a minimum of 8 weeks' therapy, the researchers found that mean pain scores decreased from 7.26 to 2.49, and that 28 women achieved at least a 50% reduction in pain scores. Among the 20 evaluable women with localized vulvodynia, they also found that 17 reported improved sexual function.
Boardman LA, Cooper AS, Blais LR, et al. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008;112:579-585.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More